---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-072407"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:54:01.868530+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Monte Rosa Therapeutics 2024 annual meeting results: directors elected, auditor ratified

## Summary
- Markus Warmuth, M.D. elected with 39,473,886 votes for, 84,415 withheld; Ali Behbahani, M.D. with 23,794,947 for, 15,763,354 withheld.
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 approved: 40,409,003 for, 59,893 against, 3 abstentions.
- No other matters were submitted to a vote at the June 12, 2024 annual meeting.

## SEC filing metadata
- accession: 0000950170-24-072407
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/0000950170-24-072407-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/glue-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-072407
- JSON: https://secwatch.observer/filing/0000950170-24-072407.json
- Plain text: https://secwatch.observer/filing/0000950170-24-072407.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.